Expert Video - How does AML classification help predict treatment outcomes?
Dr. Jamile Shammo, an expert on acute myeloid leukemia (AML), explains how AML classification helps predict treatment outcomes. Based on the genetics of your AML, doctors will classify your AML as favorable, intermediate, or adverse riskgroup (good, medium, or poor). Along with your age and other factors (such as your general health), your risk group helps determine your treatment plan.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.